2,977
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Bibliometric analysis of chloride channel research (2004–2019)

, , , , , , , & show all
Pages 393-402 | Received 19 Sep 2020, Accepted 02 Oct 2020, Published online: 24 Oct 2020

In recent years, both cation [Citation1]and anion channels [Citation2,Citation3] have emerged as significant molecules with aberrant expression, activity, and localization in various pathological conditions such as cardiovascular dysfunction, neurological disorders, metabolic diseases, and cancers. The main class of anion channels associated with multiple pathological disorders are chloride channels. Chloride channels are widely present in the cell membranes and organelle membranes of organisms. The chloride channels can transport not only Cl but also I, Br, F, NO3, PO43- and even negatively charged amino acids, so some people called it anion channel.

All the known chloride channels can be classified as members of the voltage-sensitive CLC subfamily, ligand-gated chloride channels such asγ-aminobutyric acid (GABA), and glycine receptors, calcium-activated chloride channels such as TMEM16A [Citation4], high conductance chloride channels, the cystic fibrosis transmembrane conductance regulator (CFTR), and volume-regulated channels [Citation5].

The opening of the chloride channel is related to membrane voltage, intracellular ATP hydrolysis, cell expansion, intracellular H+, Ca2+ concentration, intracellular residue phosphorylation, and cell signaling molecule binding.

Chloride channels are involved in a wide range of biological functions, including stabilization of cell membrane potential, maintenance of intracellular pH, cell proliferation, fluid secretion, regulation of cell volume, and acidification of intracellular organelles [Citation5].

Mutations in several chloride channels cause human diseases, including cystic fibrosis, macular degeneration, myotonia, kidney stones, renal salt wasting, and hyperekplexia. Chloride channel modulators have potential applications in the treatment of some of these disorders, as well as in secretory diarrheas, polycystic kidney disease, osteoporosis, and hypertension.

A bibliometric study can calculate the productivity of institutions, countries, authors, and the frequency of keywords to explore research hotspots/frontiers in specific fields [Citation6,Citation7]. Through bibliometric analysis, researchers can summarize the current situation and development trends of research fields or specific diseases, and provide directions and ideas for future research [Citation8]. CiteSpace and VOSviewer are the commonly used bibliometric visualization tools for data analysis and visualization [Citation9,Citation10].

Although chloride channels have been a hotspot of multidisciplinary research for decades, no bibliometric studies regarding the trends in chloride channel research activity have been published. Here, we collected scientific publications on chloride channel research in the past 16 years, using bibliometrics and visual analysis to explore the hotspots and frontier directions of chloride channel research and hope to provide researchers with some useful guidance.

The data search was conducted on 25 June 2020. The retrieved data were collected within one day to avoid any potential deviation due to the daily updating of the database. The search keywords entered into the database were as follows: TS = (chloride channel* OR chloride ion channel* OR Clˉ channel* OR CFTR) and language: (English). The data for analysis were retrieved from the Science Citation Index Expanded (SCI-expanded) of Web of Science Core Collection (WoSCC) database from 2004 to 2019.

In this study, the data were downloaded directly from the database as secondary data without further animal experiments. Therefore, no ethical approval was required.

Twenty-five thousand three hundred and seventy publications were obtained, and the following documents were excluded: meeting abstract (3,251), review (2,235), (proceedings) paper (578), editorial material (401), book chapter (142), letter (129), correction (79), early access (13), retracted publication (5), news item (4), biographical item (1). Eighteen thousand six hundred fifty-two articles were analyzed. The retrieval strategy of the experiments is shown in . We used the VOSviewer 1.6.11 to identify top countries, institutions, authors, and journals. The CiteSpace 5.6 R4 was used to analyze keywords, co-cited references, and trends.

Figure 1. Flow chart of chloride channel researches inclusion

Figure 1. Flow chart of chloride channel researches inclusion

Eighteen thousand six hundred and fifty-two articles about chloride channel were published from 2004 to 2019. To explore the trends of chloride channel research, we showed the number of articles per year in the form of a histogram. As shown in , there was an increasing trend for the number of research publications on the chloride channel, with the average annual number of publications being 1,166. The number of published articles on the chloride channel steadily increased from 2005 through 2011, and then the number of publications increased dramatically from 2012 onwards. The annual number of articles published in 2012, 2013, and 2015 was more than 1,200, which was the rapid development period of chloride channel research. In 2019, the activity in chloride channel research reached a peak.

Figure 2. The number of annual publications on chloride channel research from 2004 to 2019

Figure 2. The number of annual publications on chloride channel research from 2004 to 2019

Co-occurrence map provides valuable information and helps researchers to identify the cooperative relationship [Citation11]. lists the top 10 countries and institutions contributed to publications on the chloride channel. Countries and institutions co-occurrence maps are shown in .

Table 1. The top 10 countries and institutions contributed to publications on chloride channel research

Researchers from more than 125 countries/territories contributed to the 18,652 articles on chloride channel research. The USA, Peoples R China, Germany, Japan, and England were the top five productive countries (). The United States published the most papers (6,688 articles), followed by China (2,683 articles), and they were the two critical countries in chloride channel research. shows that American institutions published most of the publications. The University of California (University of California, San Francisco) produced the highest number of publications on chloride channels (510), followed by University of Toronto (283) and Chinese Academy of Sciences (279).

Figure 3. The analysis of countries and institutions. (a). Network of countries/territories engaged in chloride channel research; (b).Network of institutions engaged in chloride channel research

Figure 3. The analysis of countries and institutions. (a). Network of countries/territories engaged in chloride channel research; (b).Network of institutions engaged in chloride channel research

The 18,652 articles were published in 2,755 journals. lists the top 10 journals that published articles on chloride channel research. The journal of biological chemistry had the highest number at 549 (2.943%) (IF2019 = 4.328), followed by Plos One published 460 papers (2.466%) (IF2019 = 2.74 and the American journal of physiology.cell physiology ranked third at 266 articles (1.426%) (IF2019 = 3.485).

Table 2. The top 10 journals that published articles on chloride channel research

Author co-occurrence map can provide information on influential research groups and potential collaborators. It can help researchers to find potential collaborators [Citation12].

More than 70,000 authors contributed 18,652 articles related to chloride channel research. shows the network of authors contributed to chloride channel research, and the top10 active authors are listed in . In the network of authors contributed to chloride channel research, the largest node was Kunzelmann, Karl (82 articles) who mainly focused on TMEM16A and its role in disease [Citation13,Citation14]. Rowe, Steven M. was the second highly published author. His research focused on the mechanisms underlying the development and natural progression of the airway mucus defect in cystic fibrosis (CF) [Citation15] and the clinical research of patients with cystic fibrosis homozygous for the F508del mutation [Citation16].

Figure 4. The network of authors contributed to chloride channel research

Figure 4. The network of authors contributed to chloride channel research

Table 3. The top10 active authors in chloride channel research

Eighteen thousand six hundred and fifty-two articles were visualized and analyzed using CiteSpace with a time span from 2004 to 2019, and a time slice of 1 was chosen for the analysis of the co-cited references. The network of co-cited references on chloride channels consists of references with higher centrality and citation counts which is presented in . The highly cited references were analyzed to determine the key knowledge base in the field. The top 10 highest co-cited references are summarized in . Caputo A, Yang YD, and Schroeder BC mainly focused on TMEM16A, which is a membrane protein associated with calcium-dependent chloride channel activity [Citation17–19]. The highly co-cited references on TMEM16A were mainly published in 2008. In 2002, Ma TH found that thiazolidinone CFTR inhibitors may be useful in developing large-animal models of cystic fibrosis and in reducing intestinal fluid loss in cholera and other secretory diarrheas [Citation20]. Van Goor F mainly focuses on the treatment of cystic fibrosis. In 2009, his research showed that VX-770 could restore CFTR function and rescue epithelial cell function in the human CF airway [Citation21]. Two years later, he discovered that VX-809 represents a type of CFTR corrector, explicitly solving the underlying processing defects in F508del-CFTR [Citation22]. In 2011, Ramsey BW indicated that ivacaftor (VX-770), a CFTR potentiator, was associated with improvements in lung function in subjects with cystic fibrosis [Citation23]. In 2015, Wainwright, CE showed that lumacaftor in combination with ivacaftor provided a benefit for patients with cystic fibrosis homozygous for the Phe508del CFTR mutation [Citation24]. The publications on the molecular structure and physiological functions of chloride channels laid the foundation for the in-depth study of chloride channels in 2002 [Citation25,Citation26].

Figure 5. The analysis of Co-cited references: Co-citation network of references from publications on chloride channel research

Figure 5. The analysis of Co-cited references: Co-citation network of references from publications on chloride channel research

Table 4. The top10 Co-cited references (CR) in chloride channel research

shows the top 15 research areas that appeared in publications related to chloride channel research from 2004 to 2019. Biochemistry and molecular biology, cell biology, pharmacology pharmacy are the three areas where chloride channels are more studied.

Figure 6. The 15 research areas on chloride channel research

Figure 6. The 15 research areas on chloride channel research

Keywords represent the main content of research. Keyword co-occurrence analysis provides a reasonable description of research hotspots, and burst keywords can represent research frontiers over a period of time [Citation27].

CiteSpace 5.6.R4 were used to construct acknowledge map of keyword co-occurrence () and identified the top 20 keywords in chloride channel research articles from 2004 to 2019 (), according to frequency. The top keywords were “cystic fibrosis,” “expression,” “transmembrane conductance regulator,” “mutation,” “mechanism,” “protein,” “activation,” “cell,” “identification,” “Transport,” “gene,” “in vitro,” “inhibition,” “disease,” “calcium,” “receptor,” “in vitro,” “epithelial cell,” “membrane,” “crystal structure,” “potassium channel.” Therefore, research hotspots can be summarized in the following aspects:

Table 5. Top 20 keywords in terms of frequency in chloride channel research

1. Cystic fibrosis

Cystic fibrosis (CF), a genetic disorder observed in people of all races and ethnicities, affects approximately 80,000 people worldwide. In 1989, the discovery that mutations cause CF in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which leads to abnormal ion transport in mucous membranes throughout the body. Further affect the function of the respiratory, gastrointestinal, and reproductive tracts [Citation28,Citation29].

2. Identification of cystic fibrosis transmembrane conductance regulator (CFTR) modulator

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators are a class of small molecule drugs that improve the activity of the defective CFTR protein in people with cystic fibrosis, resulting in improved pulmonary function, reduction of pulmonary exacerbations, and improved nutrition. Ivacaftor, a CFTR potentiator, was the first modulator to be approved by the United States FDA in 2012 and is currently available to people with CF and responsive mutations who are at least 6 months old. When ivacaftor is combined with CFTR correctors, it improves the function of the most common CFTR mutation, F508del. Combination lumacaftor/ivacaftor and tezacaftor/ivacaftor were approved for patients homozygous for F508del in 2015 and 2018, respectively. For people homozygous for F508del, the improvement in pulmonary function is modest, so these combinations are not considered highly effective modulators. Both are ineffective for F508del heterozygotes who have a second minimal function mutation. In October 2019, the triple combination elexacaftor/tezacaftor/ivacaftor was approved by the US FDA, providing a highly effective modulator for people with CF who are homozygous or heterozygous for F508del [Citation30].

3. Calcium-activated chloride channel

TMEM16A, a protein encoded by the gene ANO1, is a calcium-activated chloride channel robustly expressed not only in epithelial cells but also in smooth muscle cells of airways, pulmonary, and systemic vessels, gastrointestinal smooth muscle cells, and the endothelial cells of pulmonary arteries [Citation31]. TMEM16A dysfunction is implicated in many diseases such as cancer, hypertension, and cystic fibrosis [Citation32]. Recent research shows that enhancing the activity of TMEM16A increases epithelial fluid secretion and enhances mucus clearance independent of CFTR function. TMEM16A potentiation is a novel approach for the treatment of patients with CF and non-CF muco-obstructive diseases [Citation33].

Figure 7. The analysis of keywords in chloride channel research

Figure 7. The analysis of keywords in chloride channel research

Keywords were identified and analyzed using strong citation bursts () to explore the frontiers of research. In , the red line indicates the time period during which the burst keyword appears [Citation34]. As shown in , the keywords that had strong bursts after 2017 were “g551d mutation,” “phe508del cftr,” “cystic fibrosis patient,” “voltage,” “insecticide,” ‘vx 770ʹ, “guinea pig,” “atp binding,” ‘atp release’ and “insecticide resistance.” The top four research frontiers of calcium channel research were as follows:

  1. The CFTR mutation locus

Table 6. Top 23 keywords with the strongest citation bursts

CFTR is the first single-gene disease gene discovered nearly 30 years ago [Citation35]. CFTR is an ATP-gated, cAMP-dependent chloride channel. The basic biophysical and pathological functions of CFTR are related with the secretion of chloride ion in epithelial cells and tissues. Mutations in CFTR cause cystic fibrosis. Investigation and research found that more than 2,000 mutations have been found in the human CFTR gene, of which more than 300 are pathogenic [Citation36], approximately 70% of all CF patients are caused by the deletion of the F508 locus, the other two most common mutations are the G542X mutation and the G551D mutation.

  1. The clinical trial of VX-770 in the treatment of cystic fibrosis

VX-770 is an investigational, orally bioavailable CFTR potentiator. In 2009, Van Goor F showed that VX-700 increased the activity of wild-type and defective cell surface CFTR protein in vitro. In 2012, a study evaluated the safety and adverse-event profile of VX-770 in patients with cystic fibrosis and the G551D-CFTR mutation. The results showed that VX-770 was associated with within-subject improvements in CFTR and lung function [Citation37]. The small molecule compound drug VX-770 is now only useful for patients with the G551D mutation, and its therapeutic effect needs further study.

  1. Insecticides that act on GABA receptors

There are four main insect nervous system targets of known insecticides: acetylcholinesterase, nicotinic acetylcholine receptor, γ-aminobutyric acid (GABA), and sodium ion channels. The GABA receptor (GABA receptor chloride channel complex) is considered to be one of the most critical insecticides and nematicide targets. GABA is an inhibitory neurotransmitter released from the presynaptic terminal of the nervous system of insects and mammals [Citation38].

Based on the WOSCC database, bibliometric and Visual analysis were used to study the characteristics of chloride channel research results from 2004 to 2019. Over the past 16 years, the number of publications on the chloride channel has been on the rise. The three hot spots of chloride channel research were “cystic fibrosis,” “identification of cystic fibrosis transmembrane conductance regulator (CFTR) modulator,” and “calcium-activated chloride channel.” The top three research frontiers were “the CFTR mutation locus,” “clinical trial of VX-770 in the treatment of cystic fibrosis,” and “insecticides that act on GABA receptors.” Bibliometric analysis of the literature on the chloride channels was important in allowing researchers to identify cooperations, find research hotspots, and predict the frontiers of chloride channel research.

Disclosure statement

The authors report no conflicts of interest in this work.

Additional information

Funding

This study was supported by the Beijing Municipal Natural Science Foundation [7172188] and the Innovative Funding for PhD Students at China Academy of Chinese Medical Sciences.

References

  • Toro L, Li M, Zhang Z, et al. MaxiK channel and cell signalling. Pflugers Arch. 2014;466(5):875–886.
  • Ponnalagu D, Singh H. Anion channels of mitochondria. Handb Exp Pharmacol. 2017;240:71-101.
  • Rao SG, Ponnalagu D, Patel NJ, et al. Three decades of chloride intracellular channel proteins: from organelle to organ physiology. Curr Protoc Pharmacol. 2018;80: 11.21.1–11.21.17.
  • Crottès D, Jan LY. The multifaceted role of TMEM16A in cancer. Cell Calcium. 2019;82:102050.
  • Rao SG, Patel NJ, Singh H. Intracellular chloride channels: novel biomarkers in diseases[J]. Front Physiol. 2020;11:96.
  • Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014). Expert Opin Biol Ther. 2014;14(9):1295–1317.
  • Wang Q, Yang Z, Yang Y, et al. A bibliometric analysis of research on the risk of engineering nanomaterials during 1999–2012. SciTotal Environ. 2014;473:483–489.
  • Lu C, Bing Z, Bi Z, et al. Top-100 most cited publications concerning network pharmacology: a bibliometric analysis. Evid Based Complement Alternat Med. 2019;2019:1–7.
  • Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Nat Acad Sci. 2004;101(suppl 1):5303–5310.
  • Nees Jan van E, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538.
  • Zhao D, Li J, Seehus C, et al. Bibliometric analysis of recent sodium channel research. Channels. 2018;12(1):311–325.
  • Liang YD, Li Y, Zhao J, et al. Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res. 2017;10:951.
  • Ousingsawat J, Martins JR, Schreiber R, et al. Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport. J Chem Biol. 2009;284(42):28698–28703.
  • Duvvuri U, Shiwarski DJ, Xiao D, et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012;72(13):3270–3281.
  • Birket SE, Davis JM, Fernandez CM, et al. Development of an airway mucus defect in the cystic fibrosis rat. Jci Insight. 2018;3(1). DOI:10.1172/jci.insight.97199
  • Heijerman HGM, McKone EF, Downey DG, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomized, phase 3 trial. Lancet. 2019;394(10212):1940–1948.
  • Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 2008;322(5901):590–594.
  • Yang YD, Cho H, Koo JY, et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. 2008;455(7217):1210–1215.
  • Schroeder BC, Cheng T, Jan YN, et al. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell. 2008;134(6):1019–1029.
  • Ma T, Thiagarajah JR, Yang H, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110(11):1651–1658.
  • Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A. 2009;106(44):18825–18830.
  • Van Goor F, Hadida S, Grootenhuis PD, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A. 2011;108(46):18843–18848.
  • Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365(18):1663–1672.
  • Wainwright CE, Elborn JS, Ramsey BW, et al. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med. 2015;373(3):220–231.
  • Jentsch TJ, Stein V, Weinreich F, et al. Molecular structure and physiological function of chloride channels. Physiol Rev. 2002;82(2):503–568.
  • Dutzler R, Campbell EB, Cadene M, et al. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature. 2002;415(6869):287–294.
  • Shi J, Shi S, Shi S, et al. Bibliometric analysis of potassium channel research[J]. Channels (Austin). 2020;14(1):18–27.
  • Koivula FNM, McClenaghan NH, Harper AGS, et al. Islet-intrinsic effects of CFTR mutation. Diabetologia. 2016;59(7):1350–1355.
  • Taylor-Cousar JL. CFTR modulators: impact on fertility, pregnancy,and lactation in women with cystic fibrosis. J Clin Med. 2020;9(9):2706.
  • Savant AP, McColley SA. Cystic fibrosis year in review 2019: section 1 CFTR modulators. Pediatr Pulmonol. 2020:1–7.
  • Oh U, Jung J. Cellular functions of TMEM16/anoctamin. Pfluegers Archiv Eur J Physiol. 2016;468(3):443–453.
  • Ma K, Wang H, Yu J, et al. New insights on the regulation of Ca2+ -activated chloride channel TMEM16A. J Cell Physiol. 2017;232(4):707–716.
  • Danahay HL, Lilley S, Fox R, et al. TMEM16A potentiation: a novel therapeutic approach for the treatment of cystic fibrosis. Am J Respir Crit Care Med. 2020;201(8):946–954.
  • Zhou X, Zhao G. Global liposome research in the period of 1995–2014: a bibliometric analysis. Scientometrics. 2015;105(1):231–248.
  • Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–1073.
  • Ivanov M, Matsvay A, Glazova O, et al. Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis. BMC Med Genomics. 2018;11(S1):13.
  • Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363(21):1991–2003.
  • Christopher H, Thierry C, Pierre C, et al. expression of GABA receptor-like subunits LCCH3 and GRD reveals functional diversity of Apis mellifera GABA receptors. Br J Pharmacol. 2020;177(17):3924–3940.